| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | +12.4% |
| Cost of Revenue | $899K | +10.9% |
| Gross Profit | $1.3M | +13.1% |
| R&D Expense | $316K | +4.6% |
| SG&A Expense | $3.3M | -18.1% |
| Operating Income | -$2.3M | +28.8% |
| Interest Expense | $287K | +100.7% |
| Income Tax | $0 | — |
| Net Income | -$2.4M |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $334K | -4.3% |
| Accounts Receivable | $474K | +59.1% |
| Inventory | $141K | +151.8% |
| Current Assets | $1.0M | +30.1% |
| Total Assets | $1.1M | +29.3% |
| Current Liabilities | $938K | +28.0% |
| Total Liabilities | $6.2M | +67.7% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +20.4% |
| Financing Cash Flow | $2.0M | +12.0% |
| +28.4% |
| EPS (Basic) | -$0.02 | +33.3% |
| EPS (Diluted) | -$0.02 | +33.3% |
| Stockholders' Equity |
| -$5.1M |
| -78.6% |